SGLT2 inhibitor-induced glycosuria improves steatotic liver disease in parallel with enhanced ureagenesis in ob/ob mice. - Kidoguchi S; Kitada K; Morishita A; Tsuji Y; Ohsaki H; Yamazaki D; Morikawa T; Konishi Y; Kobara H; Yokoo T; Titze J; Takahashi K; et al. (Journal of pharmacological sciences, 2026)